|
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITINGPhase 1Sponsored by Avistone Biotechnology Co., Ltd.
Actively Recruiting
PhasePhase 1
SponsorAvistone Biotechnology Co., Ltd.
Started2024-06-24
Est. completion2027-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations8 sites
View on ClinicalTrials.gov →
NCT06307795
Summary
This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age ≥ 18 years * Eastern Cooperative Oncology Group (ECOG) Performance Status: 0-1 * Life expectancy ≥ 12 weeks * Measurable disease per RECIST v1.1 * Adequate organ and marrow function as defined in the protocol * With a pathogenetic MET alteration or ROS1 alteration or NTRK alternation Exclusion Criteria: * Active infection including tuberculosis and HBV, HCV or HIV * Known active or untreated CNS metastases * Participants with carcinomatous meningitis or meningeal metastases, or spinal cord compression * Participants with serious cardiovascular or cerebrovascular diseases
Conditions2
CancerLocally Advanced or Metastatic Solid Tumors
Interventions1
Locations8 sites
Find trials near these locations
Cancer trials in San DiegoCancer trials in DenverCancer trials in OrlandoCancer trials in New YorkCancer trials in HoustonCancer trials in SeattleAll trials in CaliforniaAll trials in ColoradoAll trials in FloridaAll trials in New YorkAll trials in TexasAll trials in VirginiaAll trials in Washington
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 1
SponsorAvistone Biotechnology Co., Ltd.
Started2024-06-24
Est. completion2027-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations8 sites
View on ClinicalTrials.gov →
NCT06307795